☀ Good news for IBS patients… The investigator meeting of Vitabiotic study ☀

At the prestigious Faculty Club of KU Leuven, Prof. Jan Tack of UZ Leuven shared very promising interim data on our Vitabiotic’s clinical study.
In the 8-week open label phase, we’re seeing a high overall response rate and improvements across all key IBS symptoms, regardless of stool subtype.
🍀 It was refreshing to hear how these ingredients work both individually and synergistically to potentially deliver enhanced results. Dr. Arthur Ouwehand, Technical Fellow at IFF, highlighted the role of Lactobacillus acidophilus NCFM, while Dr. Benoit Palms, Chief Business Officer at BiOkuris, discussed the critical roles of fungal chitin-glucan and VitD3 in BK002’s formula.

⚡ The energy from this meeting has reignited our excitement as we eagerly await the final results. We remain fully committed to advancing the frontier of gut health innovation! 💡💊